Detalles de la búsqueda
1.
Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study.
Circulation
; 147(17): 1264-1276, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866664
2.
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Circulation
; 148(14): 1113-1126, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782695
3.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335828
4.
Early feasibility studies in the United States: Focus on electrophysiology.
J Cardiovasc Electrophysiol
; 34(10): 2158-2162, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807957
5.
Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways "LEAN" working group.
J Vasc Surg
; 78(5): 1313-1321, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524153
6.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation
; 143(5): 479-500, 2021 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523728
7.
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry.
Am Heart J
; 254: 102-111, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36007567
8.
Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program.
Am Heart J
; 232: 71-83, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33157067
9.
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
Circulation
; 140(3): 240-261, 2019 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116032
10.
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).
Eur Heart J
; 40(25): 2070-2085, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992264
11.
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Eur Heart J
; 40(31): 2632-2653, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116395
12.
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
Circulation
; 137(24): 2635-2650, 2018 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891620
13.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Circulation
; 137(9): 961-972, 2018 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29483172
14.
Drug-Coated Devices for Peripheral Arterial Disease.
N Engl J Med
; 384(2): 99-101, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502835
15.
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
Eur Heart J
; 39(23): 2192-2207, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29897428
16.
Patent Foramen Ovale after Cryptogenic Stroke - Assessing the Evidence for Closure.
N Engl J Med
; 377(11): 1006-1009, 2017 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28902595
17.
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
Am Heart J
; 230: 93-97, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33011148
18.
The medical device development ecosystem: Current regulatory state and challenges for future development: A review.
Cardiovasc Revasc Med
; 60: 95-101, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778922
19.
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.
Am Heart J
; 165(3): 344-53.e1, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23453103
20.
Application of Investigational Device Exemptions regulations to endograft modification.
J Vasc Surg
; 57(3): 823-5, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23446122